Transcutaneous Oxygen Tension Measurement in Patients with Chronic Arterial Obstructive Disease: Reliability and Long-Term variability of the Method

Although transcutaneous oxygen tension (TcpO2) measurement may be useful for assessing changes in regional perfusion induced over time by drug or surgical treatment in patients with chronic arterial obstructive disease (CAOD), the reliability of the method over a long-term period is not know To approach this problem, the authors evaluated retrospectively the behavior of TcpO2 measurement over time in patients with CAOD. To eliminate confounding influences due to the concomitant vascular disease at the limb level, data analysis was performed on TcpO2 measured at the right infraclavicular position. The median length of follow-up ranged from twenty days in 34 patients to 832 days in 3 patients (n=2 and n=10 individual sequential replications respectively). Initial and final TcpO 2 values did not differ significantly even at the longest follow-up term, which indicates that the parameter is constant over time. The intrapatient variation coefficient of TcpO2 (calculated over at least three individual replications) ranged between an average of 11% to 16.2%. The corresponding interpatient variation fluctuated between 15.5% and 33.4%, a variability explained to some extent by sex-related influ ences, but, at least in the range of this sample, not by age, arterial oxygen levels, or disease status. Thus TcpO2 levels per se are stable, implying that TcpO2 measurement has the potential to record consistent changes caused by specific therapeutic interventions or the clinical evolution of patients with CAOD. However, the intrapatient and interpa tient variability of the method has to be taken into account when TcpO2 is used for the follow-up and the physiopathologic study of patients with CAOD.

[1]  R. Pedrinelli,et al.  Trancutaneous oxygen tension during long-term stimulation as a treatment for critical leg ischemia , 1992 .

[2]  P. Glasziou,et al.  Estimating an individual's true cholesterol level and response to intervention. , 1991, JAMA.

[3]  T. Rooke,et al.  Variability and Reproducibility of Transcutaneous Oxygen Tension Measurements in the Assessment of Peripheral Vascular Disease , 1989, Angiology.

[4]  R. Pedrinelli,et al.  Dietary Sodium Change in Primary Aldosteronism Atrial Natriuretic Factor, Hormonal, and Vascular Responses , 1988, Hypertension.

[5]  A. Peitzman,et al.  Transcutaneous oxygen measurements in lower extremity ischemia: effects of position, oxygen inhalation, and arterial reconstruction. , 1988, Surgery.

[6]  A. Creutzig,et al.  Transcutaneous oxygen pressure measured at two different electrode core temperatures in healthy volunteers and patients with arterial occlusive disease. , 1987, International journal of microcirculation, clinical and experimental.

[7]  F. Ameli,et al.  Transcutaneous oxygen tension during exercise in patients with claudication. , 1986, British medical journal.

[8]  C A Carlsson,et al.  Epidural Electrical Stimulation in Severe Limb Ischemia: Pain Relief, Increased Blood Flow, and a Possible Limb‐saving Effect , 1985, Annals of surgery.

[9]  C. Mehringer,et al.  Assessment of Perfusion in the Diabetic Foot by Regional Transcutaneous Oximetry , 1984, Diabetes.

[10]  W. Abbott,et al.  Utility of transcutaneous oxygen tension measurements in peripheral arterial occlusive disease. , 1984, Journal of vascular surgery.

[11]  F A Matsen,et al.  Transcutaneous oxygen tension measurements on limbs of diabetic and nondiabetic patients with peripheral vascular disease. , 1984, Surgery.

[12]  W. Shoemaker,et al.  Use of a Transcutaneous PO2 Regional Perfusion Index to Quantify Tissue Perfusion in Peripheral Vascular Disease , 1983, Annals of surgery.

[13]  R. Smithwick Lumbar sympathectomy in the treatment of obliterative vascular disease of the lower extremities. , 1957, Surgery.